1. Home
  2. JYNT vs TELO Comparison

JYNT vs TELO Comparison

Compare JYNT & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • TELO
  • Stock Information
  • Founded
  • JYNT 2010
  • TELO 2021
  • Country
  • JYNT United States
  • TELO United States
  • Employees
  • JYNT N/A
  • TELO N/A
  • Industry
  • JYNT Multi-Sector Companies
  • TELO
  • Sector
  • JYNT Miscellaneous
  • TELO
  • Exchange
  • JYNT Nasdaq
  • TELO NYSE
  • Market Cap
  • JYNT 154.2M
  • TELO 154.1M
  • IPO Year
  • JYNT 2014
  • TELO 2024
  • Fundamental
  • Price
  • JYNT $11.40
  • TELO $4.93
  • Analyst Decision
  • JYNT Strong Buy
  • TELO
  • Analyst Count
  • JYNT 2
  • TELO 0
  • Target Price
  • JYNT $17.50
  • TELO N/A
  • AVG Volume (30 Days)
  • JYNT 51.3K
  • TELO 225.7K
  • Earning Date
  • JYNT 03-13-2025
  • TELO 02-12-2025
  • Dividend Yield
  • JYNT N/A
  • TELO N/A
  • EPS Growth
  • JYNT N/A
  • TELO N/A
  • EPS
  • JYNT N/A
  • TELO N/A
  • Revenue
  • JYNT $120,795,620.00
  • TELO N/A
  • Revenue This Year
  • JYNT $3.28
  • TELO N/A
  • Revenue Next Year
  • JYNT N/A
  • TELO N/A
  • P/E Ratio
  • JYNT N/A
  • TELO N/A
  • Revenue Growth
  • JYNT 5.26
  • TELO N/A
  • 52 Week Low
  • JYNT $9.10
  • TELO $3.11
  • 52 Week High
  • JYNT $17.82
  • TELO $20.72
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 62.25
  • TELO 54.20
  • Support Level
  • JYNT $10.08
  • TELO $4.61
  • Resistance Level
  • JYNT $11.73
  • TELO $5.17
  • Average True Range (ATR)
  • JYNT 0.51
  • TELO 0.44
  • MACD
  • JYNT 0.16
  • TELO 0.05
  • Stochastic Oscillator
  • JYNT 84.65
  • TELO 79.31

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company leading the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Share on Social Networks: